Skip to content

Author

Pablo Corral

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Elevated lipoprotein(a) and prevalent cardiovascular disease burden in treated hypertension.

In adults with treated HTN, elevated Lp(a) was independently associated with prevalent cardiovascular disease burden after adjustment for office BP control and conventional cardiovascular risk factors, and the potential role of Lp(a) assessment in refining cardiovascular risk stratification in treated hypertensive popu...

N. Renna, M. Arrupe, J. Soumoulou et al. · 0 citations
Aug 2026

The hidden atherogenic burden of lipoprotein(a): Reclassification by risk-weighted apoB in a multicenter registry.

BACKGROUND AND AIMS Apolipoprotein B (apoB) is the preferred marker of atherogenic particle burden, but it assumes that all apoB-containing lipoproteins confer the same cardiovascular risk. Mendelian randomization studies suggest that triglyceride-rich lipoproteins (TRLs) and lipoprotein(a) [Lp(a)] are more atherogenic...

Pablo Corral, M. G. Matta, Sebastián Garcia-Zamora et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.